Breast Milk News and Research

RSS

Lack of fish oil fatty acids can limit brain growth during fetal development and early in life

While recent reports question whether fish oil supplements support heart health, UC Irvine scientists have found that the fatty acids they contain are vitally important to the developing brain.

16 Apr 2015

Breastfeeding not a cure-all front-line strategy to prevent obesity, research shows

Biologic research does not support breastfeeding as a cure-all front-line strategy to prevent obesity. Yes, while breastfeeding is the optimal first food for a baby, it's not as simple to say that it will protect all children from becoming obese.

10 Apr 2015

Breastfeeding is not a frontline strategy to prevent obesity, say researchers

A new study supports human milk as the optimal first food for babies, but the study raises questions about whether breast milk protects children from becoming obese.

7 Apr 2015

Breast milk purchased online has significant amounts of cow's milk added, study finds

A study published today on the safety of human breast milk bought over the Internet found that 10 percent of samples contained added cow's milk. The discovery that purchased samples of human milk may be purposely "topped off" with cow's milk or infant formula confirms a danger for the large number of babies receiving the purchased milk due to medical conditions.

6 Apr 2015

Shire announces availability of Natpara (parathyroid hormone) for injection in U.S.

Shire plc today announced that Natpara (parathyroid hormone) for injection is now available in the United States. The U.S. Food and Drug Administration approved Natpara as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism on January 23, 2015.

1 Apr 2015

Glyxambi for Type 2 diabetes treatment now available by prescription across the U.S.

Glyxambi® (empagliflozin/linagliptin) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S., including Walgreens and Rite Aid.

23 Mar 2015

Milk protein comparison study may help improve infant formula

Human babies appear to need more of a nutritional boost from breast-milk proteins than do infants of one of their closest primate relatives, suggests a study comparing human milk with the milk of rhesus macaque monkeys.

20 Mar 2015

Longer duration of breastfeeding linked with increased intelligence

Longer duration of breastfeeding is linked with increased intelligence in adulthood, longer schooling, and higher adult earnings, a study following a group of almost 3,500 newborns for 30 years published in The Lancet Global Health journal has found.

19 Mar 2015

Academy of Nutrition and Dietetics highlights positive effects of human milk on infants, maternal health

Human milk provides the best nutrition for most babies and breastfeeding provides the best nutrition for infants and very young children, according to an updated position paper from the Academy of Nutrition and Dietetics.

6 Mar 2015

Two persistent organic environmental pollutants affect infant growth

Even though the levels of two environmental pollutants have declined over the last 20 years, they may still have adverse effects on children's development, according to a new study by the Norwegian Institute of Public Health. This is the largest study of environmental pollutants and infant growth to date.

6 Mar 2015

Common flame retardants linked to obesity, say UH researchers

Could your electronics be making you fat? According to University of Houston researchers, a common flame retardant used to keep electronics from overheating may be to blame.

5 Mar 2015

Formula-fed infants have higher arsenic levels than breast-fed infants

In the first U.S. study of urinary arsenic in babies, Dartmouth College researchers found that formula-fed infants had higher arsenic levels than breast-fed infants, and that breast milk itself contained very low arsenic concentrations.

23 Feb 2015

New research finds that synthetic flame retardants can cause metabolic and liver problems

Chemicals used as synthetic flame retardants that are found in common household items such as couches, carpet padding, and electronics have been found to cause metabolic and liver problems that can lead to insulin resistance, which is a major cause of obesity, according to new research from the University of New Hampshire.

20 Feb 2015

Study: Infant gut microbiota associated with healthy weight gain

Researchers in Singapore and UK as part of the EpiGen consortium worked together with scientists at the Nestlé Research Center, Switzerland, on a new study on the bacterial makeup of the gut (gut microbiota) of infants in Singapore. Their study reveals that the rate of bacterial colonisation of the gut is influenced by external factors such as the method of delivery and duration of gestation.

5 Feb 2015

Maternal exposure to flame-retardants may contribute to preterm births

Researchers at The University of Texas Medical Branch have determined that maternal exposure to high levels of flame-retardants may be a contributing factor in preterm births.

28 Jan 2015

Loyola University Medical Center earns Baby-Friendly designation

Loyola University Medical Center has earned the coveted Baby-Friendly designation. This verifies that the hospital has implemented the ten steps to help new mothers successfully breastfeed.

23 Jan 2015

Janssen, Gilead to jointly develop darunavir-based, single-tablet regimen for HIV treatment

Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.

29 Dec 2014

Abbvie’s HOLKIRA PAK for chronic genotype 1 Hepatitis C treatment receives Health Canada approval

AbbVie receives Health Canada approval for HOLKIRA PAK (ombitasvir/paritaprevir/ritonavir film-coated tablets; dasabuvir film-coated tablets), an all-oral, short-course (12 weeks for the majority of patients), interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including those with cirrhosis.

23 Dec 2014

Cell-associated HIV transmission contributes to HIV epidemic

Dr. Deborah Anderson from Boston University School of Medicine (BUSM) and her colleagues are challenging dogma about the transmission of the human immunodeficiency virus type 1 (HIV-1).

22 Dec 2014

FDA approves AbbVie's VIEKIRA PAK for treatment of patients with GT1 HCV infection

The U.S. Food and Drug Administration has approved AbbVie's VIEKIRA PAK, an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis.

21 Dec 2014